| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
200 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
187 |
| Net Income (TTM) (Millions $) |
-356 |
| Cash Flow (TTM) (Millions $) |
-52 |
| Capital Exp. (TTM) (Millions $) |
19 |
Business Description
Human Genome Sciences Inc (HGS) was a biopharmaceutical company that focused on discovering, developing, and commercializing drugs in the field of genomics. Founded in 1992, HGS aimed to utilize the human genome to identify and target disease-related genes to develop innovative therapeutics.
One of HGS's major achievements was the discovery and development of Benlysta (belimumab), which became the company's flagship product. Benlysta was the first new drug approved for systemic lupus erythematosus (SLE), a chronic autoimmune disease, in over 50 years. It generated substantial revenue for the company and became a breakthrough treatment for patients suffering from SLE.
In addition to Benlysta, HGS had a robust pipeline of potential therapeutics targeting various diseases such as cancer, hepatitis C, and infectious diseases. The company collaborated with other pharmaceutical companies to leverage their expertise and resources in bringing these drugs to market.
HGS also had a strong research and development foundation, with a focus on genomics, proteomics, and monoclonal antibody technology. The company aimed to identify drug targets, develop potential therapeutics, and conduct clinical trials to validate their efficacy and safety.
In 2012, HGS was acquired by GlaxoSmithKline (GSK), a leading pharmaceutical company, for approximately $3 billion. This acquisition further strengthened GSK's research capabilities in the field of genomics and expanded their portfolio of innovative drugs.
Overall, HGS played an essential role in advancing genomics-based drug discovery and development, particularly with the discovery of Benlysta. The company's acquisition by GSK demonstrated the significant value and potential of their scientific initiatives and drug pipeline.
|
%